Medicine Image
Medicine Name:
Generic Name:
Company Name:
0.88 mg (1 vial)
Fill Form For Medicine Enquiry   

What is IRESSA (Gefinitib)?
IRESSA is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

For treatment related information, please consult your treating Physician..

How supplied:
250mg (30 tabs)

Storage and handling:
Store at 20° to 25° C, excursions permitted to 15° to 30° C

How do we source the Drug?
SSPWL sources its drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.

Company that Manufactures/ Markets:
M/s AstraZeneca

Assistance Cell in India:
For ONCOLOGY DRUG: IRESSA (gefitinib)price.

Contact Us
Call: +91 07738100125 / +91 07738151650 or